268 related articles for article (PubMed ID: 8419332)
1. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
Retsky KL; Freeman MW; Frei B
J Biol Chem; 1993 Jan; 268(2):1304-9. PubMed ID: 8419332
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein.
Retsky KL; Frei B
Biochim Biophys Acta; 1995 Aug; 1257(3):279-87. PubMed ID: 7647104
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation.
Retsky KL; Chen K; Zeind J; Frei B
Free Radic Biol Med; 1999 Jan; 26(1-2):90-8. PubMed ID: 9890644
[TBL] [Abstract][Full Text] [Related]
4. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation.
Frei B; Gaziano JM
J Lipid Res; 1993 Dec; 34(12):2135-45. PubMed ID: 8301232
[TBL] [Abstract][Full Text] [Related]
5. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro.
Muna ZA; Doudin K; Songstad J; Ulvik RJ; Berge RK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3255-62. PubMed ID: 9409320
[TBL] [Abstract][Full Text] [Related]
6. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
Burkitt MJ
Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
[TBL] [Abstract][Full Text] [Related]
7. Vitamin C protects low-density lipoprotein from homocysteine-mediated oxidation.
Alul RH; Wood M; Longo J; Marcotte AL; Campione AL; Moore MK; Lynch SM
Free Radic Biol Med; 2003 Apr; 34(7):881-91. PubMed ID: 12654477
[TBL] [Abstract][Full Text] [Related]
8. Ascorbic acid protects against peroxidative modification of low-density lipoprotein, maintaining its recognition by LDL receptors.
Sakuma N; Yoshikawa M; Hibino A; Sato A; Kamiya Y; Ohte N; Tamai N; Kijnimatsu M; Kimura G; Inoue M
J Nutr Sci Vitaminol (Tokyo); 2001 Feb; 47(1):28-31. PubMed ID: 11349887
[TBL] [Abstract][Full Text] [Related]
9. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
[TBL] [Abstract][Full Text] [Related]
10. Oxidative modification and antioxidant protection of human low density lipoprotein at high and low oxygen partial pressures.
Hatta A; Frei B
J Lipid Res; 1995 Nov; 36(11):2383-93. PubMed ID: 8656076
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant and prooxidant effects of ascorbic acid, dehydroascorbic acid and flavonoids on LDL submitted to different degrees of oxidation.
Otero P; Viana M; Herrera E; Bonet B
Free Radic Res; 1997 Dec; 27(6):619-26. PubMed ID: 9455697
[TBL] [Abstract][Full Text] [Related]
12. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.
Neuzil J; Stocker R
J Biol Chem; 1994 Jun; 269(24):16712-9. PubMed ID: 8206992
[TBL] [Abstract][Full Text] [Related]
13. Dehydroascorbic acid prevents apoptosis induced by oxidized low-density lipoprotein in human monocyte-derived macrophages.
Asmis R; Wintergerst ES
Eur J Biochem; 1998 Jul; 255(1):147-55. PubMed ID: 9692913
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
[TBL] [Abstract][Full Text] [Related]
15. Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals.
Kapiotis S; Hermann M; Exner M; Laggner H; Gmeiner BM
Free Radic Res; 2005 Nov; 39(11):1193-202. PubMed ID: 16298745
[TBL] [Abstract][Full Text] [Related]
16. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
Maor I; Hayek T; Coleman R; Aviram M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein.
Lynch SM; Frei B
J Lipid Res; 1993 Oct; 34(10):1745-53. PubMed ID: 8245725
[TBL] [Abstract][Full Text] [Related]
18. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.
Iuliano L; Pedersen JZ; Camastra C; Bello V; Ceccarelli S; Violi F
Free Radic Biol Med; 1999 Apr; 26(7-8):858-68. PubMed ID: 10232829
[TBL] [Abstract][Full Text] [Related]
19. Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein.
Albertini R; Abuja PM
Free Radic Res; 1999 Mar; 30(3):181-8. PubMed ID: 10711788
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the oxidative modification of LDL by nitecapone.
Pentikäinen MO; Lindstedt KA; Kovanen PT
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):740-7. PubMed ID: 7773727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
